246 related articles for article (PubMed ID: 29130549)
1. Concomitant IDH wild-type glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome.
Galuppini F; Opocher E; Tabori U; Mammi I; Edwards M; Campbell B; Kelly J; Viel A; Quaia M; Rivieri F; D'Avella D; Arcella A; Giangaspero F; Fassan M; Gardiman MP
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):233-239. PubMed ID: 29130549
[No Abstract] [Full Text] [Related]
2. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
3. IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
Ferris SP; Goode B; Joseph NM; Kline CN; Samuel D; Gupta N; Bollen A; Perry A; Mueller S; Solomon DA
Acta Neuropathol; 2016 Jul; 132(1):153-5. PubMed ID: 27161253
[No Abstract] [Full Text] [Related]
4. Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation.
Amayiri N; Al-Hussaini M; Swaidan M; Jaradat I; Qandeel M; Tabori U; Hawkins C; Musharbash A; Alsaad K; Bouffet E
Childs Nerv Syst; 2016 Mar; 32(3):553-7. PubMed ID: 26293676
[TBL] [Abstract][Full Text] [Related]
5. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
[TBL] [Abstract][Full Text] [Related]
6. Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient.
Medress ZA; Xu LW; Ziskin JL; Lefterova MI; Vogel H; Li G
Clin Neuropathol; 2015; 34(2):96-8. PubMed ID: 25295857
[No Abstract] [Full Text] [Related]
7. Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.
Kerpel A; Yalon M; Soudack M; Chiang J; Gajjar A; Nichols KE; Patay Z; Shrot S; Hoffmann C
AJNR Am J Neuroradiol; 2020 May; 41(5):904-910. PubMed ID: 32354708
[TBL] [Abstract][Full Text] [Related]
8. Teenage colorectal polyposis and cancer may be caused by constitutional mismatch repair deficiency (CMMRD).
Soplepmann J; Laidre P
Acta Oncol; 2016 Dec; 55(12):1503-1505. PubMed ID: 27723366
[No Abstract] [Full Text] [Related]
9. IDH1 R132H mutation in a pilocytic astrocytoma: a case report.
Behling F; Steinhilber J; Tatagiba M; Bisdas S; Schittenhelm J
Int J Clin Exp Pathol; 2015; 8(9):11809-13. PubMed ID: 26617931
[TBL] [Abstract][Full Text] [Related]
10. Paediatric systemic lupus erythematosus as a manifestation of constitutional mismatch repair deficiency.
Toledano H; Orenstein N; Sofrin E; Ruhrman-Shahar N; Amarilyo G; Basel-Salmon L; Shuldiner AR; Smirin-Yosef P; Aronson M; Al-Tarrah H; Bazak L; Gonzaga-Jauregui C; Tabori U; Wimmer K; Goldberg Y
J Med Genet; 2020 Jul; 57(7):505-508. PubMed ID: 31501241
[TBL] [Abstract][Full Text] [Related]
11. Metachronous Wilms Tumor, Glioblastoma, and T-cell Leukemia in an Child With Constitutional Mismatch Repair Deficiency syndrome due to Novel Mutation in MSH6 (c.2590G>T).
Citak EC; Sagcan F; Gundugan BD; Bozdogan ST; Yilmaz EB; Avci E; Balci Y; Karabulut YY
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e198-e202. PubMed ID: 31815888
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an
Rittberg R; Harlos C; Rothenmund H; Das A; Tabori U; Sinha N; Singh H; Chodirker B; Kim CA
Curr Oncol; 2021 Feb; 28(1):757-766. PubMed ID: 33535600
[TBL] [Abstract][Full Text] [Related]
13. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
14. Turcot's syndrome associated with intestinal non-Hodgkin's lymphoma: case report and review of literature.
Ma S; Hu Y; Yang J; Zhou X
Clin Neurol Neurosurg; 2013 Feb; 115(2):117-20. PubMed ID: 22676959
[TBL] [Abstract][Full Text] [Related]
15. Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases.
Lusis EA; Travers S; Jost SC; Perry A
Neurosurgery; 2010 Sep; 67(3):811-7; discussion 817. PubMed ID: 20657316
[TBL] [Abstract][Full Text] [Related]
16. Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome.
Farah RA; Maalouf F; Chahine NA; Farhat H; Campbell B; Zhukova N; Durno C; Aronson M; Hawkins C; Bouffet E; Tabori U
Eur J Med Genet; 2019 Aug; 62(8):103706. PubMed ID: 31233827
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma.
Sabunga OD; Kaelan C; Zainuddin AA; Sungowati NK; Cangara MH; Miskad U
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3051-3059. PubMed ID: 36172668
[TBL] [Abstract][Full Text] [Related]
19. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
Stichel D; Ebrahimi A; Reuss D; Schrimpf D; Ono T; Shirahata M; Reifenberger G; Weller M; Hänggi D; Wick W; Herold-Mende C; Westphal M; Brandner S; Pfister SM; Capper D; Sahm F; von Deimling A
Acta Neuropathol; 2018 Nov; 136(5):793-803. PubMed ID: 30187121
[TBL] [Abstract][Full Text] [Related]
20. Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report.
Søndergaard CB; Scheie D; Sehested AM; Skjøth-Rasmussen J
Childs Nerv Syst; 2017 Jul; 33(7):1217-1220. PubMed ID: 28236063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
